|
Cost of illness of hemodialysis in Indonesia: A survey from eight hospitals in Indonesia
|
|
| Author:
|
SUSI ARI KRISTINA, DWI ENDARTI, TRI MURTI ANDAYANI, HARDIKA ADITAMA
|
| Abstract:
|
Background: End-stage renal disease (ESRD) in Indonesia has a major impact on the economic burden, particularly hemodialysis treatment. The objective of this study was to estimate the cost-of-illness of hemodialysis and to examine its associated factors in Indonesia.
Methods: A cross-sectional study was conducted in 2019 and 1,365 participants with end-stage renal disease were recruited from eight hospitals representative of the western, central, and eastern regions of Indonesia. Medical records of patients have been reviewed for clinical data, and hospital administrative records were reviewed for cost data. Costs of illness were measured from a patient perspective using a bottom-up approach. The direct costs for each patient and indirect costs for each patient and their attendants have been calculated. Multiple regression analysis was performed to identify the determinants of the average annual cost.
Results: The vast majority of the patients were male (57.14%), 45-60 years of age (55.46%), and employed (57.58%). The average annual cost per patient was US$ 7845.6. The cost of hemodialysis (US$ 4217.2) was the largest proportion of the total direct cost, followed by the cost of the medicine (US$ 1286.1). Long duration of hemodialysis, comorbidity, and poor health status were significantly associated with the highest average of annual cost.
Conclusion: Since the costs of the HD procedure are all covered by country finance, it is crucial to minimize costs by developing interventions to control the prevalence of ESRD.
|
| Keyword:
|
hemodialysis, cost of illness, direct cost, indirect cost
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2021.13.01.375
|
| Download:
|
Request For Article
|
|
|